The principal investigator for the study will be James Andrews, MD, founding member of Gulf Breeze, Fla.-based Andrews Institute Orthopaedics & Sports Medicine. It will be conducted at the Andrews’ Research and Educational Institute in Pensacola, Fla.
inVentiv Health Clinical is a provider of global drug development services to pharmaceutical, biotechnology, generic drug and medical device companies.
IntelliCell BioSciences is a regenerative medicine company utilizing adult autologous stomovascular cells derived from the blood vessels found in adipose tissue.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws
